欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4082/001
药品名称Lenalidomide Sandoz 2,5 mg
活性成分
    • lenalidomide 25.0 mg
剂型Capsule, hard
上市许可持有人Sandoz.B.V. Veluwezoom 22 1327 AH Almere Netherlands
参考成员国 - 产品名称Netherlands (NL)
Lenalidomide Sandoz 2,5 mg
互认成员国 - 产品名称
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Lenalidomide Sandoz
    • Finland (FI)
    • Poland (PL)
    • Romania (RO)
      Lenalidomidă Sandoz 2,5 mg capsule
    • Slovenia (SI)
    • Greece (GR)
    • Hungary (HU)
    • Portugal (PT)
    • Austria (AT)
    • Belgium (BE)
      Lenalidomide Sandoz 2,5 mg, harde capsules
    • Bulgaria (BG)
    • Ireland (IE)
    • Germany (DE)
      Lenalidomid HEXAL 2,5 mg Hartkapseln
    • Denmark (DK)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
许可日期2018/08/08
最近更新日期2024/11/10
药物ATC编码
    • L04AX04 lenalidomide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase